L&K Biomed Ltd. (KOSDAQ:156100)

Market Cap	112.43B -13.6%
Revenue (ttm)	39.53B +10.2%
Net Income	-7.36B
EPS	-353.17
Shares Out	22.35M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	323,148
Open	6,000.00
Previous Close	4,970.00
Day's Range	4,825.00 - 6,000.00
52-Week Range	4,730.00 - 16,400.00
Beta	0.61
Analysts	n/a
Price Target	n/a
Earnings Date	May 29, 2026

About L&K Biomed

L&K Biomed Ltd., a medical company, manufactures and sells spinal implants in South Korea, the United States, Thailand, and internationally. The company offers spinal products comprising BlueEX-T, BluEX-TC, BluEX-A, BlueEX-L, and BluEX-ATP; BluEX-LT, an advanced lateral cage system for spinal lordosis restoration; PathLoc-TM, an expandable TLIF/PLIF lumbar cage system; AccelFix-XL, an expandable lateral lumbar cage system; AccelFix-XTP, an expandable lumbar cage system for anterior-to-psoas approach; and PathLoc-TA, an expandable ALIF anterior ...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 2008
• Employees: 101
• Stock Exchange: KOSDAQ
• Ticker Symbol: 156100